Friday, September 3, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Marketing
1 of 3
Previous |
Next
Marketing
Marketing from big pharma to start-up biotech
Having recently made the move from pharmaceutical giant Pfizer to California-based biotech company, Cerimon Pharmaceuticals, Inc.
No Comments
Sales and Marketing Productivity in Pharma’s New World Order
By Richard Martin and David Deutsch
The Challenge of a Company…and an Industry
No Comments
Formal segmentation research defining brand opportunity
Pharmaceutical marketers face multiple challenges in a market that is becoming increasingly more challenging every day.
No Comments
Customers know best – or do they?
Customer choice plays more significant part in drug selection
No Comments
e-tractions: Whole Brain Goodness
Award winning creative and the numbers to back it up. We like to call it: digital marketing for both sides of the brain.
No Comments
1 of 3
Previous |
Next
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.